These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1680624)

  • 1. Geometric isomerization of doxepin during its N-demethylation in humans.
    Ghabrial H; Prakash C; Tacke UG; Blair IA; Wilkinson GR
    Drug Metab Dispos; 1991; 19(3):596-9. PubMed ID: 1680624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin.
    Yan JH; Hubbard JW; McKay G; Midha KK
    Xenobiotica; 1997 Dec; 27(12):1245-57. PubMed ID: 9460230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics of doxepin isomers.
    Midha KK; Hubbard JW; McKay G; Hawes EM; Korchinski ED; Gurnsey T; Cooper JK; Schwede R
    Eur J Clin Pharmacol; 1992; 42(5):539-44. PubMed ID: 1607001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin.
    Haritos VS; Ghabrial H; Ahokas JT; Ching MS
    Pharmacogenetics; 2000 Oct; 10(7):591-603. PubMed ID: 11037801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of doxepin by Cunninghamella elegans.
    Moody JD; Freeman JP; Cerniglia CE
    Drug Metab Dispos; 1999 Oct; 27(10):1157-64. PubMed ID: 10497142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative GLC determination of cis- and trans-isomers of doxepin and desmethyldoxepin.
    Rosseel MT; Bogaert MG; Claeys M
    J Pharm Sci; 1978 Jun; 67(6):802-5. PubMed ID: 660461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of urinary metabolites of doxepin in patients.
    Shu YZ; Hubbard JW; Cooper JK; McKay G; Korchinski ED; Kumar R; Midha KK
    Drug Metab Dispos; 1990; 18(5):735-41. PubMed ID: 1981729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective and simultaneous measurement of cis- and trans-isomers of doxepin and N-desmethyldoxepin in plasma or urine by high-performance liquid chromatography.
    Yan J; Hubbard JW; McKay G; Midha KK
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):131-8. PubMed ID: 9140766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of the cis- and trans-isomers of doxepin and desmethyldoxepin after administration of doxepin to patients.
    Bogaert MG; Rosseel MT; Deberdt R; Vranckx C
    Arzneimittelforschung; 1981; 31(1):113-5. PubMed ID: 7194087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin.
    Hrdina PD; Bakish D; Swenson S; Lapierre YD
    Ther Drug Monit; 1990 Mar; 12(2):129-33. PubMed ID: 2315969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective measurement of E- and Z-doxepin and its N-desmethyl and hydroxylated metabolites by gas chromatography-mass spectrometry.
    Haritos VS; Ghabrial H; Ahokas JT; Ching MS
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):201-8. PubMed ID: 10677000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability and stereoselective pharmacokinetics of doxepin.
    Yan JH; Hubbard JW; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 2002 Jul; 32(7):615-23. PubMed ID: 12162857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy.
    Negrusz A; Moore CM; Perry JL
    J Anal Toxicol; 1998 Oct; 22(6):531-6. PubMed ID: 9788530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of doxepin and N-desmethyldoxepin in human milk.
    Kemp J; Ilett KF; Booth J; Hackett LP
    Br J Clin Pharmacol; 1985 Nov; 20(5):497-9. PubMed ID: 4074620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isomeric metabolites of doxepin in equine serum and urine.
    Hagedorn HW; Meiser H; Zankl H; Schulz R
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):317-23. PubMed ID: 12062692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of E- and Z-doxepin and E- and Z-desmethyldoxepin by high-performance liquid chromatography.
    Adamczyk M; Fishpaugh JR; Harrington C
    Ther Drug Monit; 1995 Aug; 17(4):371-6. PubMed ID: 7482692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of two doxepin products.
    Wecker MT; Woodworth JR; Amsel LP; Hinsvark ON; Rotenberg KS
    Clin Ther; 1986; 8(3):342-7. PubMed ID: 3719617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage schedule and plasma levels of doxepin and desmethyldoxepin.
    Biggs JT; Preskorn SH; Ziegler VE; Rosen SH; Meyer DA
    J Clin Psychiatry; 1978 Oct; 39(10):740-2. PubMed ID: 711683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability investigation of two different oral formulations of doxepin.
    Geister U; Gaupp M; Arnold P; Schaarschmidt D; Doser K; Renner J
    Arzneimittelforschung; 2001; 51(3):189-96. PubMed ID: 11304934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fatal intoxication due to doxepin.
    Cordonnier J; Heyndrickx A; Jordaens L; Brijs R; De Keyser R
    J Anal Toxicol; 1983; 7(4):161-4. PubMed ID: 6632797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.